Showing 1 - 16 results of 16 for search '"narcolepsy"', query time: 0.04s Refine Results
  1. 1

    Narcolepsy: Pathophysiology and Neuropsychological Changes by Angela Naumann, Irene Daum

    Published 2003-01-01
    “…Narcolepsy is now recognized as a distinctive disorder with specific pathophysiology and neurochemical abnormalities. …”
    Get full text
    Article
  2. 2
  3. 3

    Successful Treatment of Narcolepsy and Cataplexy: A Review by B Lockrane, P Bhatia, Robin Gore

    Published 2005-01-01
    “…A 25-year-old woman with narcolepsy and cataplexy was treated with well-recognized drugs for these conditions. …”
    Get full text
    Article
  4. 4

    Treatment Dilemmas in a Young Man Presenting with Narcolepsy and Psychotic Symptoms by Victoria Fernandez, Sharon Davies, Nicola Walters

    Published 2011-01-01
    “…Psychotic features can be present in both narcolepsy and psychosis, which can result in challenges in diagnosis and management. …”
    Get full text
    Article
  5. 5
  6. 6

    A Case of REM Sleep Behavior Disorder, Narcolepsy-Cataplexy, Parkinsonism, and Rheumatoid Arthritis by Filomena I. I. Cosentino, Angela Distefano, Giuseppe Plazzi, Carlos H. Schenck, Raffaele Ferri

    Published 2014-01-01
    “…A patient is reported in whom signs and symptoms of REM sleep behavior disorder (RBD) and narcolepsy have been associated for almost two decades with a late development of parkinsonism and rheumatoid arthritis. …”
    Get full text
    Article
  7. 7

    Intravenous Immunoglobulin Therapy Administered Early after Narcolepsy Type 1 Onset in Three Patients Evaluated by Clinical and Polysomnographic Follow-Up by Elisabeth Ruppert, Hélène Zagala, Juliette Chambe, Henri Comtet, Ulker Kilic-Huck, François Lefebvre, Marc Bataillard, Carmen Schroder, Laurent Calvel, Patrice Bourgin

    Published 2018-01-01
    “…Narcolepsy type 1 is a rare disabling sleep disorder mainly characterized by excessive daytime sleepiness and cataplexy, an emotion-triggered sudden loss of muscle tone. …”
    Get full text
    Article
  8. 8

    pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy by Noeen Sarfraz, David Okuampa, Hannah Hansen, Mark Alvarez, Elyse M. Cornett, Juyeon Kakazu, Adam M. Kaye, Alan D. Kaye

    Published 2022-05-01
    “…Common causes of delayed and incorrect diagnoses of these conditions include lack of physician familiarity with narcolepsy symptoms and comorbidities which mask narcolepsy signs and symptoms. …”
    Get full text
    Article
  9. 9

    Sleep-related drugs utilization and suicide behaviors: a population-based study in China by Yunshu Zhang, Bo Liu, Keqing Li, Hailing Jia, Hemin Shi, Yongqiao Liu, Jianfeng Li, Long Sun

    Published 2025-01-01
    “…Insomnia, sleep apnea, rapid eye movement sleep behavior disorder (RBD), and narcolepsy were assessed using the Athens Insomnia Scale, Berlin Questionnaire, Rapid Eye Movement Sleep Behavior Disorder Questionnaire, and Ullanlinna Narcolepsy Scale, respectively. …”
    Get full text
    Article
  10. 10

    Causal Effects of Sleep Traits on Angina Pectoris: Mediation by Cardiovascular Risk Factors by Zeng C, Ke Y, Li H, Zhang C, Chen J, Chen M

    Published 2025-02-01
    “…Our study aims to declare the causality of sleep traits on AP by Mendelian randomization (MR) analyses.Methods: Genome-wide association study (GWAS) data of sleep traits (sleep duration, insomnia, nap during day, chronotype, getting up in morning, narcolepsy, snoring) were obtained from the UK Biobank. …”
    Get full text
    Article
  11. 11

    Genetic Associations Between Specific Sleep-Related Phenotypes and Idiopathic Sudden Sensorineural Hearing Loss: A Mendelian Randomization Analysis by Li M, He J, Liang Y, Zou F, Gou C, Lv J, Zhang X, Li D, Yu Z

    Published 2025-02-01
    “…There were no evidence indicating a potential causal effect of insomnia, sleep duration, sleep disorders, sleep apnoea, and on the risk of ISSHNL. However, narcolepsy was an inferred protective factor for ISSNHL. …”
    Get full text
    Article
  12. 12

    Sleep Paralysis and Hallucinosis by Gregory Stores

    Published 1998-01-01
    “…Less common forms are either part of the narcolepsy syndrome or (rarely) they are familial in type. …”
    Get full text
    Article
  13. 13

    Insomnia: definition, pathophysiological models, diagnosis, and treatment by E. Sakalauskaitė-Juodeikienė, R. Masaitienė

    Published 2018-09-01
    “…Polysomnography is recommended when other sleep disorders (periodic limb movement disorder, sleep apnea or narcolepsy) are suspected, also for treatment-resistant insomnia. …”
    Get full text
    Article
  14. 14

    Microwave coprocessing of modafinil with Gelucire®: Thermal and compression characteristics by Derar Omari, Assayed Sallam, Iyad Rashid, Shereen M. Assaf, Faisal Akayleh, Khaldoun A. Al-Sou′od

    Published 2025-01-01
    “… Introduction: Modafinil, a wakefulness-promoting agent, is primarily used to treat excessive daytime sleepiness associated with narcolepsy and fatigue. As a BCS class II drug, modafinil exhibits low solubility and high permeability, with its crystalline structure significantly impacting dissolution, bioavailability, and compressibility. …”
    Get full text
    Article
  15. 15

    Preclinical Polymodal Hallucinations for 13 Years before Dementia with Lewy Bodies by Carlo Abbate, Pietro Davide Trimarchi, Silvia Inglese, Niccolò Viti, Alessandra Cantatore, Lisa De Agostini, Federico Pirri, Lorenza Marino, Renzo Bagarolo, Daniela Mari

    Published 2014-01-01
    “…Finally, it confirms an association between hallucinations and visuoperceptual impairments at an intermediate stage of the disease course and strongly supports the hypothesis that hallucinations in the earliest stages of DLB may reflect a narcolepsy-like REM-sleep disorder.…”
    Get full text
    Article
  16. 16

    Valerenic acid ameliorates amphetamine-related neurotoxicity by improving hypothalamus tyrosine hydroxylase and histamine-N-methyl transferase enzymes by Khaled M.M. Koriem, Ammar H.A. Naiem

    Published 2025-06-01
    “…Background: Narcolepsy, obesity, and attention deficit hyperactivity disorder are all treated with amphetamine (a central nervous system stimulant) while valerenic acid (VA) has a pharmacological effect in the central nervous system. …”
    Get full text
    Article